GB0328773D0 - Pharmaceutical formulation of fluticasone propionate - Google Patents

Pharmaceutical formulation of fluticasone propionate

Info

Publication number
GB0328773D0
GB0328773D0 GBGB0328773.7A GB0328773A GB0328773D0 GB 0328773 D0 GB0328773 D0 GB 0328773D0 GB 0328773 A GB0328773 A GB 0328773A GB 0328773 D0 GB0328773 D0 GB 0328773D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical formulation
fluticasone propionate
fluticasone
propionate
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0328773.7A
Other versions
GB2392915B (en
GB2392915A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en
Priority claimed from GB0014451A external-priority patent/GB0014451D0/en
Priority claimed from GB0018654A external-priority patent/GB0018654D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority claimed from GB0320477A external-priority patent/GB2388843B/en
Publication of GB0328773D0 publication Critical patent/GB0328773D0/en
Publication of GB2392915A publication Critical patent/GB2392915A/en
Application granted granted Critical
Publication of GB2392915B publication Critical patent/GB2392915B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
GB0328773A 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate Expired - Fee Related GB2392915B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
GB0014451A GB0014451D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
GB0018654A GB0018654D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation
GB0320477A GB2388843B (en) 1999-09-11 2000-09-11 A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate

Publications (3)

Publication Number Publication Date
GB0328773D0 true GB0328773D0 (en) 2004-01-14
GB2392915A GB2392915A (en) 2004-03-17
GB2392915B GB2392915B (en) 2004-04-28

Family

ID=30773574

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0328773A Expired - Fee Related GB2392915B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate
GB0328426A Expired - Fee Related GB2392164B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0328426A Expired - Fee Related GB2392164B (en) 1999-09-11 2000-09-11 Pharmaceutical formulation of fluticasone propionate

Country Status (1)

Country Link
GB (2) GB2392915B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
BR112018011266B1 (en) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Pharmaceutical composition, sealed container, and, methods for treating a patient suffering from or prone to suffering from a respiratory disorder and for stabilizing a pharmaceutical composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1166811B1 (en) * 1995-04-14 2006-12-06 SmithKline Beecham Corporation Metered dose inhaler for fluticasone propionate
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
GB2392164A (en) 2004-02-25
GB2392164B (en) 2004-04-07
GB0328426D0 (en) 2004-01-14
GB2392915B (en) 2004-04-28
GB2392915A (en) 2004-03-17

Similar Documents

Publication Publication Date Title
EG24044A (en) pharmaceutical formulation of omeprazole
PL352282A1 (en) Derivatives of thiazoles and pharmaceutical compositions containing these derivatives
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
HUP0201872A3 (en) Steroid compounds and pharmaceutical compositions of the same
ITRM20000491A0 (en) PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE.
AU4328800A (en) Pharmaceutical formulation
IL159576A0 (en) Pharmaceutical formulation for the intramuscular administration of fulvestrant
IL154403A0 (en) Pharmaceutical formulation of salmeterol and fluticasone propionate
AU2002237400A1 (en) Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate
GB2392915B (en) Pharmaceutical formulation of fluticasone propionate
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them
GB9909154D0 (en) Pharmaceutical formulation
GB0312326D0 (en) Pharmaceutical formulation of fluticasone propionate
HUP0200311A3 (en) Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions
GB9926251D0 (en) Pharmaceutical formulation
HUP0203596A3 (en) 3-methylene steroid derivative and pharmaceutical compositions containing them
AU1172001A (en) Compounds and pharmaceutical compositions comprising same
GB9921289D0 (en) Pharmaceutical aerosol formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
GB9927685D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20120911